Br J Haematol. 2024;205(1):356-359.
Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.
제1저자 김동현 · 교신저자 변자민, 고영일
소속 (5)
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
- Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Korea.
그 밖의 정보
- 출판 형태
- Clinical Trial, Phase II, Letter
- 저널
- British journal of haematology · eISSN 1365-2141
- 전자 출판
- 2024-05-03
- MeSH
- Humans · Antilymphocyte Serum* / therapeutic use · Anemia, Aplastic* / drug therapy · Triazoles* / therapeutic use · Male · Female · Myelodysplastic Syndromes / drug therapy / complications · Adult · Middle Aged · Antifungal Agents / therapeutic use · Aged
- Substances
- Antilymphocyte Serum · posaconazole · Triazoles · Antifungal Agents
- 참고문헌
- 15편